Stocktoria
Merck & Co., Inc. MRK
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 1941-01-01
Merck & Co., Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net margin | 28.1% | 26.7% | 0.6% | 24.5% | 26.8% |
| FCF margin | 19.0% | 28.2% | 15.2% | 24.8% | 17.8% |
| Return on assets | 13.3% | 14.6% | 0.3% | 13.3% | 12.3% |
| Return on equity | 34.7% | 36.9% | 1.0% | 31.5% | 34.1% |
| Debt / equity | 0.89× | 0.74× | 0.89× | 0.62× | 0.80× |
| Current ratio | 1.54 | 1.36 | 1.25 | 1.47 | 1.27 |
| Revenue growth | 1.3% | 6.7% | 1.4% | 21.7% | 17.3% |
Source: SEC EDGAR filings · CIK 0000310158 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.